Llwytho...
Vitamin D Deficiency Increases Severity of Paclitaxel-Induced Peripheral Neuropathy
PURPOSE: Approximately 25% of patients receiving weekly paclitaxel for breast cancer require treatment disruptions to avoid severe, irreversible peripheral neuropathy (PN). Vitamin insufficiencies are PN risk factors in many diseases, but their relevance to chemotherapy-induced PN is unknown. METHOD...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Breast Cancer Res Treat |
|---|---|
| Prif Awduron: | , , , , , , , , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
2020
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7945004/ https://ncbi.nlm.nih.gov/pubmed/32166478 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-020-05584-8 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|